Examples of Initial Growth Capital Advance in a sentence
Thereafter, until September 30, 2021, Borrower may request and Bank shall make additional growth capital advances in an aggregate amount not to exceed Three Million Dollars ($3,000,000) (each, a “Supplemental Growth Capital Advance”, and together with the Initial Growth Capital Advance, each, a “Growth Capital Advance” and collectively, the “Growth Capital Advances”).
Additionally, upon the Federal Drug Administration’s approval of OFIRMEV, Lenders agree, severally and not jointly, to make additional Growth Capital Advances in an amount not to exceed Ten Million Dollars ($10,000,000) (the “Secondary Growth Capital Advance”) prior to the Growth Capital Commitment Termination Date; provided, the aggregate Growth Capital Advances outstanding hereunder (including the Initial Growth Capital Advance) shall not exceed the Growth Capital Loan Commitment.
Lenders shall apply the proceeds from the Initial Growth Capital Advance to refinance the amounts outstanding to each Lender with respect to the Existing Term Loans.2.2 Termination of Commitment to Lend.
Lenders shall apply the proceeds from the Initial Growth Capital Advance to refinance the amounts outstanding to each Lender with respect to the Existing Term Loans.
Lenders shall withhold from the disbursement of the Initial Growth Capital Advance an amount equal to their respective pro-rata amounts in accordance with their respective Commitment Percentages (as defined under the Original Agreement) owing by Borrower for the total Existing Term Loans in the amount of $375,000 (the “Existing Term Loans Final Payment”).(e) Lenders Expenses.
Lenders shall withhold from the disbursement of the Initial Growth Capital Advance an amount equal to their respective pro-rata amounts in accordance with their respective Commitment Percentages (as defined under the Original Agreement) owing by Borrower for the total Existing Term Loans in the amount of $375,000 (the “Existing Term Loans Final Payment”).
Additionally, upon the Federal Drug Administration’s approval of OFIRMEV, Lenders agree, severally and not jointly, to make additional Growth Capital Advances in an amount not to exceed Ten Million Dollars ($10,000,000) prior to the Growth Capital Commitment Termination Date; provided, the aggregate Growth Capital Advances outstanding hereunder (including the Initial Growth Capital Advance) shall not exceed the Growth Capital Loan Commitment.